BRKR – bruker corporation (US:NASDAQ)

News

Bruker Announces Appointment of Thierry Bernard to its Board of Directors
PreOmics GmbH and Biognosys AG Prevail in U.S. Patent Challenge
Bruker (BRKR) had its price target lowered by Guggenheim from $58.00 to $50.00. They now have a "buy" rating on the stock.
Bruker (BRKR) had its "sell (d+)" rating reaffirmed by Weiss Ratings.
Here's Why Bruker's (BRKR) Positive Momentum Returned in Q4 [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com